# Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.

> **NCT06631391** · PHASE1 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 30 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **BIOLOGICAL:** umbilical cord blood NK cells

## Key facts

- **NCT ID:** NCT06631391
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2029-11-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06631391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06631391, "Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06631391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*